United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 15, 2026 · Filed May 18, 2026

On May 15, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$568.11 for US$5.4M under a trading plan, leaving 40,513 shares. Filed May 18, 2026 (Form 4).

Sold
9,500 shares
Price
US$568.11 average (US$566.19 to US$572.25)
Value
US$5.4M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 15, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 15, 2026Common StockSale1,477US$566.1948,536Direct
May 15, 2026Common StockSale1,874US$567.0446,662Direct
May 15, 2026Common StockSale3,211US$568.0743,451Direct
May 15, 2026Common StockSale1,682US$569.0341,769Direct
May 15, 2026Common StockSale616US$569.9441,153Direct
May 15, 2026Common StockSale320US$571.2340,833Direct
May 15, 2026Common StockSale320US$572.2540,513Direct

Source

View original at SEC

Related